Drawing for JULÄINE

USPTO serial 79428025

JULÄINE

Reviewed by CopyMark Law Group

Reg. 8362564Status 700Registered
Filing date
Status date
Registration date
Jul 28, 2026
Examiner
VAGHANI, MAYUR C
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with JULÄINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; make-up; cosmetic preparations for skin care; skin texturizers; non-medicated anti-aging skincare preparations; wrinkle removing skin care preparations; non-medicated lip care preparations; skin care creams, other than for medical use; body cream; beauty care cosmeticsACTIVE
005Dermatological pharmaceutical preparations; dermatological pharmaceutical products; injectable dermal fillers; anaesthetic preparation for injection; pharmaceutical preparations, namely, injectable dermal filler, injectable poly-l-lactic acid for use in non-surgical restorative and beauty care treatment of wrinkles fine lines, folds, scars, lips, for face and body contouring, rejuvenating the skin and stimulation of collagen production; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Dermatological pharmaceutical products for use in filling out wrinkles, folds, scars, and lips, for face and body contouring, for rejuvenating the skin and for stimulation of collagen production; Dermatological pharmaceutical products, namely, biostimulatory injectable dermal filler implant; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for stimulation of collagen production; Dermatological pharmaceutical products, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable dermal implant for non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely injectable dermal implant for stimulation of collagen productionACTIVE
010Medical apparatus and devices, namely, injection needles for use with biostimulatory injectable dermal filler implant; Medical apparatus and devices, namely, injection needles for use with biostimulatory injectable dermal filler implant medical device; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles for use with injectable poly-llactic acid for stimulation of collagen production; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for stimulation of collagen production; medical therapy instruments in the nature of an injection needle; hypodermic injection apparatus, namely, hypodermic needles, medical syringes and disposable syringes; hypodermic syringes for injections for medical purposes; injection needles for medical useACTIVE
044Dermatological services for treating skin conditions; beauty consultancy; beauty treatment services of the body and face; beauty care services; beauty information services; beauty therapy treatments, namely, cosmetic body care services in the nature of cosmetic skin care services, including non-surgical treatment of fine lines and wrinkles, and the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles; beauty therapy treatment services, namely, non-invasive cosmetic body care services and cosmetic face care services; beauty therapy treatment services, namely cosmetic skincare treatment services in the nature of providing an injectable dermal filler to reduce the appearance of facial fine lines; cosmetic skin care services, namely, injection of dermal filling treatment for cosmetic skin careACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 28, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 9, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 16, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 22, 2025RFNTREFUSAL PROCESSED BY IB
Nov 5, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 5, 2025RFRRREFUSAL PROCESSED BY MPU
Sep 17, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2025DOCKASSIGNED TO EXAMINER
Jul 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jul 30, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance